Anheuser-Busch InBev SA/ NV stock: Buy ratings pile up amid steady growth

Fresh buy ratings from Jefferies and others highlight Anheuser-Busch InBev's resilient beer empire as revenue climbs. For investors eyeing global consumer staples, this stock offers scale and brand power across continents. ISIN: BE0974293251

You’re looking at Anheuser-Busch InBev SA/NV, the beer giant behind icons like Budweiser, Corona, and Stella Artois, and wondering if its stock fits your portfolio right now. With recent buy ratings from firms like Jefferies maintaining a €75 target, the shares traded around €63 on Euronext Brussels in EUR, drawing attention from global investors seeking stability in consumer goods. Quarterly revenue rose 6.2% year-over-year, underscoring a business that keeps pouring profits even in choppy markets.

As of: 09.04.2026

By Elena Vargas, Senior Equity Analyst: Anheuser-Busch InBev dominates the global brewing landscape with unmatched brand reach and operational scale.

The Brewing Powerhouse: What Makes ABI Tick

You know those cold beers at the game or beach—many come from Anheuser-Busch InBev SA/NV, or ABI as insiders call it. This Belgian-based behemoth, listed on Euronext Brussels under ISIN BE0974293251 in EUR, brews the world’s top-selling beers, holding a portfolio that spans premium lagers to craft options. Its scale is massive: over 131,000 employees fuel production across continents, with brands like Budweiser reaching 100+ countries.

The core business splits into beer (the overwhelming majority) and smaller non-beer lines like soft drinks. Annual revenue hit $59.38 billion for the fiscal year ending December 31, 2023, reflecting a robust operation where gross profit alone topped $31.98 billion after cost of goods sold. For you as an investor, this means a company with deep moats—brand loyalty, distribution networks, and pricing power that few rivals match.

Geographically, ABI diversifies risk smartly. North America, powered by Budweiser and Michelob, anchors stability, while Latin America—especially Brazil via majority-owned Ambev—drives growth. Asia-Pacific and EMEA add layers, with sales breakdowns showing Brazil and EMEA as key pillars despite varying regional paces. This global footprint shields you from single-market slumps, making ABI a staple for diversified portfolios.

Financial Engine: Revenue, Margins, and Returns

Dig into the numbers, and ABI’s financial health shines through consistent metrics that savvy investors like you prioritize. Net margin stands at 11.53%, with return on equity at 15.67%, numbers that signal efficient capital use and profitability. Net income reached $6.84 billion on that $59.38 billion revenue base, proving the model converts sales to bottom-line gains effectively.

Quarterly revenue growth of 6.2% year-over-year shows momentum persists, even as ABI navigates post-pandemic shifts. Historical trends reveal resilience: revenue evolved from lower bases in prior years to the current scale, supported by cost controls—cost of goods sold at $27.40 billion leaves room for healthy gross margins. You’re not betting on hype here; these are proven throughput numbers from a debt-managed giant.

For U.S., European, or global investors, this translates to reliable dividends and buybacks when conditions allow. ABI’s focus on free cash flow generation—key for weathering cycles—positions it well against smaller brewers. Watch how management allocates this cash: debt reduction or shareholder returns could boost your total yield.

Analyst Views: Buy Signals from the Street

Reputable banks are leaning positive on Anheuser-Busch InBev SA/NV stock, with Jefferies issuing a buy rating on April 9, 2026, via analyst Edward Mundy, keeping the target at €75 amid shares near €63. This echoes a broader consensus: 26 analysts rate it a buy on average, with a mean target implying solid upside from recent levels. Recent notes from Bernstein, UBS, and JP Morgan also back buy calls, signaling confidence in ABI’s trajectory.

These views stem from ABI’s operational strength—revenue growth, margin expansion, and global diversification—that analysts see sustaining through cycles. For you, this isn’t fringe opinion; it’s from established houses tracking the stock closely. While Erste Group expressed caution on FY2026 earnings, the dominant tone favors accumulation, especially for long-term holders.

Mean consensus points to buy, with average targets well above current trading, offering a potential 18%+ lift. U.S. investors via BUD ADR, Europeans on Euronext, or globals get the same exposure to this optimism. Always cross-check with your risk tolerance, but the Street’s alignment here merits your attention.

Why It Matters to You as an Investor

Whether you’re building wealth in New York, London, or Singapore, Anheuser-Busch InBev SA/NV stock slots into portfolios chasing defensive growth. Beer demand endures—recession-proof as habits stick through economic turns. With revenue diversification across regions, you gain exposure without over-relying on one economy, ideal for global English-speaking investors.

ABI’s brands command premium pricing, shielding margins from input cost spikes like barley or aluminum. For U.S. folks via BUD, it’s a familiar name with international upside; Europeans get home-turf insight. The relevance now? Steady metrics amid volatility make it a watchlist staple, potentially rewarding patience with dividends and appreciation.

Should you buy? Analysts’ buy tilt suggests yes for suitable horizons, but align with your goals—value hunters see entry at current valuations. Track upcoming Q1 2026 earnings on May 5 for confirmation. This isn’t a sprint; it’s your anchor in staples.

Risks and What to Watch Next

No stock’s risk-free, and ABI faces headwinds you need to eye. Regulatory scrutiny on alcohol, health trends favoring low/no-alc options, and currency swings in emerging markets can pressure sales. Debt from past deals lingers, though management prioritizes deleveraging—keep tabs on net debt metrics.

Competition heats up from craft brewers and spirits, nibbling premium share, while U.S. volume softness post-recent events adds caution. Watch consumer shifts: if non-beer expands meaningfully, it diversifies; otherwise, beer reliance amplifies macro risks. For you, monitor regional sales—Brazil’s pace, North America’s stability.

Next catalysts? Earnings beats, dividend hikes, or M&A that bolsters portfolio. Volatility around proxy votes or buybacks warrants vigilance. Globally, track commodity prices and trade policies affecting imports. If risks align with your tolerance, ABI’s strengths likely prevail.

Your Move: Buy, Hold, or Pass?

Wrapping it up, Anheuser-Busch InBev SA/NV stock presents a compelling case for buy-leaning investors, backed by growth, brands, and analyst support. You get global scale, solid returns, and resilience—perfect if consumer staples fit your strategy. Weigh risks, but the setup favors patient capital.

Monitor Q1 results, analyst updates, and macro cues to time right. Whether stateside or abroad, ABI’s story resonates for wealth builders. Stay informed, act deliberately.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.